| Cell line name | UACC62R |
|---|---|
| Accession | CVCL_WU69 |
| Resource Identification Initiative | To cite this cell line use: UACC62R (RRID:CVCL_WU69) |
| Comments | Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032). Omics: Deep RNAseq analysis. |
| Sequence variations | Homozygous for BRAF p.Val600Glu (c.1799T>A) (ClinVar=VCV000013961) (from parent cell line).Homozygous for PTEN p.Pro248Thrfs*5 (c.741dupA) (c.741_742insA) (ClinVar=VCV000142259) (from parent cell line). |
| Disease | Melanoma (NCIt: C3224) |
| Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|
| Hierarchy | Parent: CVCL_1780 (UACC-62) |
| Sex of cell | Sex unspecified |
| Age at sampling | Age unspecified |
| Category | Cancer cell line |
| Publications | DOI=10.1101/381806 |
| Cross-references | |
| Gene expression databases | GEO; GSM3195613
GEO; GSM3195614 |
| Other | Wikidata; Q98133801 |
| Entry history | |
| Entry creation | 05-Jul-2019 |
| Last entry update | 29-Oct-2020 |
| Version number | 3 |